Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus-Reference-Cited by-同舟云学术

Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus

Published:1991-05 Issue:1 Volume:37 Page:9-13
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ruiz-Argüelles Guillermo J.,Ruiz-Argüelles Alejandro,Lobato-Mendizábal Eduardo,Díaz-Gomez Felipe,Pacheco-Pantoja Elda,Drenkard Cristina,Alarcón-Segovia Donato

Publisher

Wiley

Subject

Hematology

Reference33 articles.

1. Thrombosis in Patients with the Lupus Anticoagulant

2. , et al.: Natural anticoagulants in systemic lupus erythematosus: Relationship of deficiencies to antiphospholipid antibodies, recent thromboses, and the antiphospholipid syndrome. J Rheumatol, in press.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients;Archives of Rheumatology;2022-05-06

2. Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis;Arthritis Research & Therapy;2019-07-18

3. FXII promotes proteolytic processing of the LRP1 ectodomain;Biochimica et Biophysica Acta (BBA) - General Subjects;2017-08

4. Changes to fibrinolysis in patients with systemic lupus erythematosus are associated with endothelial cell damage and inflammation, but not antiphospholipid antibodies;Blood Coagulation & Fibrinolysis;2016-12

5. Tissue factor pathway inhibitor and thrombin-activatable carboxypeptidase B for prediction of early atherosclerosis in gouty arthritis;Thrombosis Research;2014-08